Synergistic Effects of Lenvatinib (E7080) and MEK Inhibitors against Anaplastic Thyroid Cancer in Preclinical Models. The gene discussed is MAP2K7; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.